BCL6 and diffuse large B-cell lymphoma: More than half of our BCL6-rearranged DH-DLBCL cases were non-GCB phenotype, indicating, at least in part, that the preferential screening for DH with BCL6 rearrangement may be a clinically-informative modality for patients with the non-GCB phenotype DLBCL in Taiwan.